cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.5752288
title: Dataset: Evaluating Two Approaches to Assessing Student Progress in Cybersecurity Exercises

description: This repository contains supplementary materials for the following conference paper: V. Švábenský, R. Weiss, J. Cook, J. Vykopal, P. Čeleda, J. Mache, R. Chudovský, A. Chattopadhyay.<br> <em>Evaluating Two Approaches to Assessing Student Progress in Cybersecurity Exercises.</em><br> In Proceedings of the 53rd ACM Technical Symposium on Computer Science Education (SIGCSE 2022).<br> https://doi.org/10.1145/3478431.3499414 Preprint available at: https://arxiv.org/abs/2112.02053 <strong>How to cite</strong> If you use or build upon the materials, please use the BibTeX entry below to cite the original paper (not only this web link). <pre><code>@inproceedings{Svabensky2022evaluating, author = {\v{S}v\'{a}bensk\'{y}, Valdemar and Weiss, Richard and Cook, Jack and Vykopal, Jan and \v{C}eleda, Pavel and Mache, Jens and Chudovský, Radoslav and Chattopadhyay, Ankur}, title = {{Evaluating Two Approaches to Assessing Student Progress in Cybersecurity Exercises}}, booktitle = {Proceedings of the 53rd ACM Technical Symposium on Computer Science Education}, series = {SIGCSE '22}, location = {Providence, RI, USA}, publisher = {Association for Computing Machinery}, address = {New York, NY, USA}, month = {03}, year = {2022}, pages = {787--793}, numpages = {7}, isbn = {978-1-4503-9070-5}, url = {https://doi.org/10.1145/3478431.3499414}, doi = {10.1145/3478431.3499414}, }</code></pre> <strong>Attached content</strong> The materials include the research dataset, source code, and graphs. See the README.md file inside the attached ZIP file for more details.
description: This research was supported by ERDF project CyberSecurity, CyberCrime and Critical Information Infrastructures Center of Excellence (No. CZ.02.1.01/0.0/0.0/16_019/0000822).
DOI: 10.5281/zenodo.5752003
title: Dataset: Evaluating Two Approaches to Assessing Student Progress in Cybersecurity Exercises

description: This repository contains supplementary materials for the following conference paper: V. Švábenský, R. Weiss, J. Cook, J. Vykopal, P. Čeleda, J. Mache, R. Chudovský, A. Chattopadhyay.<br> <em>Evaluating Two Approaches to Assessing Student Progress in Cybersecurity Exercises.</em><br> In Proceedings of the 53rd ACM Technical Symposium on Computer Science Education (SIGCSE 2022).<br> https://doi.org/10.1145/3478431.3499414 Preprint available at: https://arxiv.org/abs/2112.02053 <strong>How to cite</strong> If you use or build upon the materials, please use the BibTeX entry below to cite the original paper (not only this web link). <pre><code>@inproceedings{Svabensky2022evaluating, author = {\v{S}v\'{a}bensk\'{y}, Valdemar and Weiss, Richard and Cook, Jack and Vykopal, Jan and \v{C}eleda, Pavel and Mache, Jens and Chudovský, Radoslav and Chattopadhyay, Ankur}, title = {{Evaluating Two Approaches to Assessing Student Progress in Cybersecurity Exercises}}, booktitle = {Proceedings of the 53rd ACM Technical Symposium on Computer Science Education}, series = {SIGCSE '22}, location = {Providence, RI, USA}, publisher = {Association for Computing Machinery}, address = {New York, NY, USA}, month = {03}, year = {2022}, pages = {787--793}, numpages = {7}, isbn = {978-1-4503-9070-5}, url = {https://doi.org/10.1145/3478431.3499414}, doi = {10.1145/3478431.3499414}, }</code></pre> <strong>Attached content</strong> The materials include the research dataset, source code, and graphs. See the README.md file inside the attached ZIP file for more details.
description: This research was supported by ERDF project CyberSecurity, CyberCrime and Critical Information Infrastructures Center of Excellence (No. CZ.02.1.01/0.0/0.0/16_019/0000822).
DOI: 10.2908/tgs00063
title: Dentists by NUTS 2 regions
title: Dentistes, par région NUTS 2
title: Zahnärzte, nach NUTS-2-Regionen

description: Die Daten für Zahnärzte beziehen sich auf Zahnärzte mit unmittelbarem Dienst am Patienten", d.h. Zahnärzte, die direkten Kontakt zu den Patienten als Empfänger von Dienstleistungen des Gesundheitswesens haben. Zum besseren Vergleich der Dienstleistungen im Gesundheitswesen der Mitgliedstaaten bevorzugt Eurostat das Konzept des "unmittelbaren Dienstes am Patienten" als Gradmesser, da es die Verfügbarkeit von Ressourcen im Gesundheitswesen am besten beschreibt. Allerdings verwenden die Mitgliedstaaten verschiedene Konzepte, wenn sie Daten zum Personal im Gesundheitswesen übermitteln. Deshalb können die Daten einiger Länder sich auf Zahnärzte, die "zur Verrichtung von Gesundheitsleistungen berechtigt" sind (d.h. Zahnärzte mit erfolgreichem Studienabschluss, unabhängig davon, ob sie Patientenkontakt haben oder nicht), beziehen, oder auf Zahnärzte, die in ihrem beruflichen Feld tätig sind, aber keinen Patientenkontakt haben (d.h. sie sind in Forschung, Verwaltung, etc. tätig), Im Anhang zu den Metadaten finden Sie Informationen, auf welches Konzept sich die Daten je Land beziehen."
description: Data on dentists should refer to those “immediately serving patients”, i.e. dentists who have direct contact with patients as consumers of health care services. In the context of comparing health care services across Member States, Eurostat considers that this is the concept which best describes the availability of health care resources. However, Member States use different concepts when they report the number of health care professionals. Therefore for some countries the data might refer to dentists ‘licensed to practice’ (i.e. successfully graduated dentists irrespective whether they see patients or not) or they might include dentists who work in their profession but do not see patients (i.e. they work in research, administration etc.). Please have a look in the annexes of the metadata to see for which concept these data refer to for each country.
description: Les données sur les dentistes se réfèrent à ceux directement au service des patients", c.-à-d. les dentistes qui ont un contact direct avec les patients en leur qualité de consommateurs de services de soins de santé. Dans le contexte de la comparaison des services de soins de santé entre les États membres, Eurostat considère que ce concept est celui qui décrit le mieux la disponibilité des ressources humaines dans ce secteur. Cependant, les États membres utilisent différents concepts lorsqu’ils communiquent le nombre de professionnels du secteur des soins de santé. Par conséquent, pour certains pays, les données peuvent inclure les dentistes travaillant dans le secteur des soins de santé mais qui ne voient pas de patients (c.-à-d. qu'ils travaillent dans la recherche, l'administration, etc.) ou correspondre aux dentistes "habilités à fournir des services de santé" (c.-à-d. des dentistes diplômés, qu'ils voient des patients ou non). Veuillez-vous référer aux annexes des métadonnées pour voir à quel concept ces données correspondent pour chaque pays. "
DOI: 10.5281/zenodo.3506640
title: Dataset: What Are Cybersecurity Education Papers About? A Systematic Literature Review of SIGCSE and ITiCSE Conferences

description: This repository contains supplementary materials for the following conference paper: Valdemar Švábenský, Jan Vykopal, Pavel Čeleda.<br> <em>What Are Cybersecurity Education Papers About? A Systematic Literature Review of SIGCSE and ITiCSE Conferences.</em><br> In Proceedings of the 51st ACM Technical Symposium on Computer Science Education (SIGCSE 2020).<br> https://doi.org/10.1145/3328778.3366816 Preprint available at: https://arxiv.org/abs/1911.11675 <strong>How to cite</strong> If you use or build upon the materials, please use the BibTeX entry below to cite the original paper (not only this web link). <pre><code class="language-json">@inproceedings{Svabensky2020what, author = {\v{S}v\'{a}bensk\'{y}, Valdemar and Vykopal, Jan and \v{C}eleda, Pavel}, title = {{What Are Cybersecurity Education Papers About? A Systematic Literature Review of SIGCSE and ITiCSE Conferences}}, booktitle = {Proceedings of the 51st ACM Technical Symposium on Computer Science Education}, series = {SIGCSE '20}, location = {Portland, OR, USA}, publisher = {Association for Computing Machinery}, address = {New York, NY, USA}, month = {03}, year = {2020}, pages = {2--8}, numpages = {7}, isbn = {978-1-4503-6793-6}, url = {https://doi.org/10.1145/3328778.3366816}, doi = {10.1145/3328778.3366816}, }</code></pre> <strong>Attached content</strong> The file "SIGCSE 2020 Literature Review.xlsx" is an Excel spreadsheet with three sheets corresponding to 1) all papers found by automated search, 2) manually excluded papers, and 3) papers included in the literature review. There are also three CSV files that correspond to the three individual sheets.
description: This research was supported by ERDF project CyberSecurity, CyberCrime and Critical Information Infrastructures Center of Excellence (No. CZ.02.1.01/0.0/0.0/16_019/0000822).
DOI: 10.5281/zenodo.3506639
title: Dataset: What Are Cybersecurity Education Papers About? A Systematic Literature Review of SIGCSE and ITiCSE Conferences

description: This repository contains supplementary materials for the following conference paper: Valdemar Švábenský, Jan Vykopal, Pavel Čeleda.<br> <em>What Are Cybersecurity Education Papers About? A Systematic Literature Review of SIGCSE and ITiCSE Conferences.</em><br> In Proceedings of the 51st ACM Technical Symposium on Computer Science Education (SIGCSE 2020).<br> https://doi.org/10.1145/3328778.3366816 Preprint available at: https://arxiv.org/abs/1911.11675 <strong>How to cite</strong> If you use or build upon the materials, please use the BibTeX entry below to cite the original paper (not only this web link). <pre><code class="language-json">@inproceedings{Svabensky2020what, author = {\v{S}v\'{a}bensk\'{y}, Valdemar and Vykopal, Jan and \v{C}eleda, Pavel}, title = {{What Are Cybersecurity Education Papers About? A Systematic Literature Review of SIGCSE and ITiCSE Conferences}}, booktitle = {Proceedings of the 51st ACM Technical Symposium on Computer Science Education}, series = {SIGCSE '20}, location = {Portland, OR, USA}, publisher = {Association for Computing Machinery}, address = {New York, NY, USA}, month = {03}, year = {2020}, pages = {2--8}, numpages = {7}, isbn = {978-1-4503-6793-6}, url = {https://doi.org/10.1145/3328778.3366816}, doi = {10.1145/3328778.3366816}, }</code></pre> <strong>Attached content</strong> The file "SIGCSE 2020 Literature Review.xlsx" is an Excel spreadsheet with three sheets corresponding to 1) all papers found by automated search, 2) manually excluded papers, and 3) papers included in the literature review. There are also three CSV files that correspond to the three individual sheets.
description: This research was supported by ERDF project CyberSecurity, CyberCrime and Critical Information Infrastructures Center of Excellence (No. CZ.02.1.01/0.0/0.0/16_019/0000822).
DOI: 10.6084/m9.figshare.21770384
title: EUSALP LULC class descriptions

description: EUSALP LULC class descriptions of 65 LULC classes
DOI: 10.6084/m9.figshare.21770438
title: EUSALP LULC map - data source layer

description: Layer showing the provenance of each pixel linking it to its source layer
DOI: 10.6084/m9.figshare.21770438.v1
title: EUSALP LULC map - data source layer

description: Layer showing the provenance of each pixel linking it to its source layer
DOI: 10.6084/m9.figshare.21770441
title: EUSALP LULC map 2020

description: A detailed LULC map of the European Alps with 65 classes and up to 5m spatial resolution
DOI: 10.6084/m9.figshare.23530008.v1
title: Supplementary Material for: Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of <i>RB1</i> Alterations in Aqueous Humor

description: <b><i>Introduction:</i></b> The aim of the study was to describe the successful conservative management of diffuse infiltrating retinoblastoma (DIR). Identification of <i>RB1</i> pathogenic variant was done after cell-free DNA (cfDNA) analysis in aqueous humor. <b><i>Case presentation:</i></b> Herein, we report 2 patients with unilateral, non-familial DIR with anterior and posterior involvement. Both patients underwent liquid biopsy for tumor cfDNA analysis in aqueous humor. Treatment consisted of a combination of systemic and intra-arterial chemotherapy, with consecutive intracameral and intravitreal injections of melphalan. One patient also required iodine-125 brachytherapy. In both cases, tumor cfDNA analysis revealed biallelic somatic alterations of the <i>RB1</i> gene. These alterations were not found in germline DNA. Both patients retained their eyes and had a useful vision after a follow-up of 2 years. <b><i>Conclusion:</i></b> In selected cases, conservative management of DIR is safe and effective. Tumor cfDNA analysis in aqueous humor is an effective technique to disclose <i>RB1</i> somatic alterations that guide the germline molecular explorations and improve genetic counseling after conservative treatment.
DOI: 10.6084/m9.figshare.23691336.v2
title: Real-Time Crowd Monitoring Dataset Based on Public Wi-Fi Infrastructure: A Case Study on the Sri Chiang Mai Smart City

description: The raw data captured from the access points is transmitted to a cloud server for storage and further processing. The collected raw data is stored in intervals of one minute, spanning from May 2022 to March 2023.
DOI: 10.6084/m9.figshare.23194757
title: Supplementary Material for: Thyroid Dysfunction After Atezolizumab and Bevacizumab is Associated with Favorable Outcomes in Hepatocellular Carcinoma

description: Introduction: Atezolizumab and bevacizumab (Ate/Bev) combination has become the new first-line systemic therapy for unresectable hepatocellular carcinoma (HCC). Although several studies reported thyroid dysfunction after treatment with immune checkpoint inhibitors, the clinical and immunological significance of thyroid dysfunction in patients treated with Ate/Bev has not been comprehensively addressed. We aimed to comprehensively evaluate the clinical and immunological implications of thyroid dysfunction in unresectable HCC patients treated with Ate/Bev. Methods: We enrolled 208 patients with unresectable HCC treated with Ate/Bev from three Korean cancer centers. Thyroid adverse events (AEs) were reviewed, and cytokines and T-cells in the blood samples were analyzed at baseline. For external validation, we analyzed clinical outcomes according to thyroid AEs in patients treated with Ate/Bev in the IMbrave150 study. Results: Forty-one (19.7%) out of 208 patients experienced thyroid dysfunction (hypothyroidism [17.3%] and thyrotoxicosis [5.8%]) after Ate/Bev treatment. Median time to onset of hypothyroidism and thyrotoxicosis after Ate/Bev treatment was 3.5 and 1.3 months, respectively. Patients with thyroid AEs demonstrated significantly better progression-free survival, overall survival, and objective response rate than those without thyroid AEs. These findings were still consistent even after adjusting for confounding factors. Furthermore, favorable survival outcomes in patients with thyroid AEs were also validated in a cohort of IMbrave150 patients. While patients with thyrotoxicosis showed a significantly lower level of baseline IL-6, those with hypothyroidism did not show significant differences in circulating cytokine levels and CD8+ T-cell fractions. Conclusions: A fraction of patients with HCC treated with Ate/Bev experienced thyroid dysfunction, and the development of thyroid AEs was associated with favorable clinical outcomes.
DOI: 10.6084/m9.figshare.23194757.v1
title: Supplementary Material for: Thyroid Dysfunction After Atezolizumab and Bevacizumab is Associated with Favorable Outcomes in Hepatocellular Carcinoma

description: Introduction: Atezolizumab and bevacizumab (Ate/Bev) combination has become the new first-line systemic therapy for unresectable hepatocellular carcinoma (HCC). Although several studies reported thyroid dysfunction after treatment with immune checkpoint inhibitors, the clinical and immunological significance of thyroid dysfunction in patients treated with Ate/Bev has not been comprehensively addressed. We aimed to comprehensively evaluate the clinical and immunological implications of thyroid dysfunction in unresectable HCC patients treated with Ate/Bev. Methods: We enrolled 208 patients with unresectable HCC treated with Ate/Bev from three Korean cancer centers. Thyroid adverse events (AEs) were reviewed, and cytokines and T-cells in the blood samples were analyzed at baseline. For external validation, we analyzed clinical outcomes according to thyroid AEs in patients treated with Ate/Bev in the IMbrave150 study. Results: Forty-one (19.7%) out of 208 patients experienced thyroid dysfunction (hypothyroidism [17.3%] and thyrotoxicosis [5.8%]) after Ate/Bev treatment. Median time to onset of hypothyroidism and thyrotoxicosis after Ate/Bev treatment was 3.5 and 1.3 months, respectively. Patients with thyroid AEs demonstrated significantly better progression-free survival, overall survival, and objective response rate than those without thyroid AEs. These findings were still consistent even after adjusting for confounding factors. Furthermore, favorable survival outcomes in patients with thyroid AEs were also validated in a cohort of IMbrave150 patients. While patients with thyrotoxicosis showed a significantly lower level of baseline IL-6, those with hypothyroidism did not show significant differences in circulating cytokine levels and CD8+ T-cell fractions. Conclusions: A fraction of patients with HCC treated with Ate/Bev experienced thyroid dysfunction, and the development of thyroid AEs was associated with favorable clinical outcomes.
DOI: 10.25318/3810016101-eng
title: Salt marsh ecosystem services account

description: Variables related to ecosystem services of salt marshes by ecozone, ecoprovince and ecoregion.
DOI: 10.6084/m9.figshare.22680517
title: A large-scale high-resolution WBC image dataset

description: The dataset comprises 16 027 single cell images of normal and pathological white blood cells, including neutrophil segments, neutrophil bands, eosinophiles, basophiles, lymphocytes, monocytes, normoblasts and blast cells of myeloid and lymphoid lineage.
DOI: 10.6084/m9.figshare.23704062
title: Peer Reviewer Training Programs Designed by Societies

description: Table summarizing a selection of reviewer training programs as dsigned by societies
DOI: 10.6084/m9.figshare.23704062.v1
title: Peer Reviewer Training Programs Designed by Societies

description: Table summarizing a selection of reviewer training programs as dsigned by societies
DOI: 10.25318/3810016101-fra
title: Compte des services écosystémiques des marais salés

description: Variables liées aux services écosystémiques des marais salais par écozone, écoprovince et écorégion.
DOI: 10.25318/3810016201-eng
title: Salt marsh ecosystem condition account

description: Variables related to the condition of salt marshes by ecozone, ecoprovince and ecoregion.
DOI: 10.25318/3810016201-fra
title: Compte de la condition écosystémique des marais salés

description: Variables liées à la condition des marais salais par écozone, écoprovince et écorégion.
DOI: 10.5281/zenodo.8160319
title: Data for Workshop at CELADE-UN in Santiago de Chile

description: Data for the computational workshop at CELADE on using Meta Movements and Population data during COVID-19
DOI: 10.5281/zenodo.8160318
title: Data for Workshop at CELADE-UN in Santiago de Chile

description: Data for the computational workshop at CELADE on using Meta Movements and Population data during COVID-19
DOI: 10.6084/m9.figshare.23566535
title: Diagnostic accuracy of interleukin-2 receptor in sarcoidosis: a systematic review and meta-analysis

description: Soluble interleukin-2 receptor (sIL-2 R), a valuable diagnostic biomarker for sarcoidosis, has been reported with variable results. Based on the literatures currently accessible, a systematic review and meta-analysis of the diagnostic performance of serum sIL-2 R for sarcoidosis were performed. Relevant studies investigating sIL-2 R for sarcoidosis diagnosis in several databases were searched and data on sensitivity, speciﬁcity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were pooled by STATA 16.0 software. Overall test performance was assessed using summary receiver operating characteristic curves and the area under the curve (AUC). Potential publication bias was assessed by Deeks test. We included eleven studies involving 1,424 subjects, with 1,099 cases of sarcoidosis and 325 of non-sarcoidosis. The pooled parameters of sIL-2 R in diagnosing sarcoidosis were summarized as follows: sensitivity, 0.85 (95% CI: 0.72–0.93); specificity, 0.88 (95% CI: 0.72–0.96); PLR, 7.3 (95% CI: 2.7–20.1); NLR, 0.17 (95% CI:0.08–0.36); DOR, 44 (95% CI: 8–231); and the AUC, 0.93 (95% CI: 0.90–0.95). No publication bias was identified (<i>P</i> = 0.64). Evidence suggests sIL-2 R performs well in diagnosing sarcoidosis. Nevertheless, results of sIL-2 R assay should be interpreted with other diagnostic examinations.
DOI: 10.6084/m9.figshare.23566535.v1
title: Diagnostic accuracy of interleukin-2 receptor in sarcoidosis: a systematic review and meta-analysis

description: Soluble interleukin-2 receptor (sIL-2 R), a valuable diagnostic biomarker for sarcoidosis, has been reported with variable results. Based on the literatures currently accessible, a systematic review and meta-analysis of the diagnostic performance of serum sIL-2 R for sarcoidosis were performed. Relevant studies investigating sIL-2 R for sarcoidosis diagnosis in several databases were searched and data on sensitivity, speciﬁcity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were pooled by STATA 16.0 software. Overall test performance was assessed using summary receiver operating characteristic curves and the area under the curve (AUC). Potential publication bias was assessed by Deeks test. We included eleven studies involving 1,424 subjects, with 1,099 cases of sarcoidosis and 325 of non-sarcoidosis. The pooled parameters of sIL-2 R in diagnosing sarcoidosis were summarized as follows: sensitivity, 0.85 (95% CI: 0.72–0.93); specificity, 0.88 (95% CI: 0.72–0.96); PLR, 7.3 (95% CI: 2.7–20.1); NLR, 0.17 (95% CI:0.08–0.36); DOR, 44 (95% CI: 8–231); and the AUC, 0.93 (95% CI: 0.90–0.95). No publication bias was identified (<i>P</i> = 0.64). Evidence suggests sIL-2 R performs well in diagnosing sarcoidosis. Nevertheless, results of sIL-2 R assay should be interpreted with other diagnostic examinations.
DOI: 10.6084/m9.figshare.23704071
title: Responses_with_labels_AR_VR_STUDY - Sheet1.csv

description: This is the response of core AR/VR developers. We made the data anonymous and added the final labeling of the open-ended questions.
DOI: 10.25318/1310087001-eng
title: Vaccine coverage estimates for recommended vaccines in children and pregnant women

description: Percentages of children and pregnant women who have received recommended vaccines, by target population and vaccine/antigen covering results from the 2011, 2013, 2015, 2017, 2019, and 2021 cycles of the Childhood National Immunization Coverage Survey.
DOI: 10.25318/1310087001-fra
title: Estimation de la couverture vaccinale pour les vaccins recommandés chez les enfants et les femmes enceintes

description: Pourcentages d'enfants et de femmes enceintes ayant reçu les vaccins recommandés, par population cible et par vaccin/antigène, selon les résultats des cycles de 2011, 2013, 2015, 2017, 2019 et 2021 de l'Enquête nationale sur la couverture vaccinale des enfants.
DOI: 10.25318/9810027101-eng
title: Knowledge of Indigenous languages by single and multiple knowledge of languages responses and Indigenous identity: Canada, provinces and territories, census metropolitan areas and census agglomerations with parts

description: Knowledge of Indigenous languages by single and multiple knowledge of languages responses, Indigenous identity, Indigenous mother tongue and age for the population in private households.